Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients ; volume:15 ; number:1 ; day:21 ; month:1 ; year:2015 ; pages:1-5 ; date:12.2015
BMC cancer ; 15, Heft 1 (21.1.2015), 1-5, 12.2015
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Mina, Alain
- Beteiligte Personen und Organisationen
-
Rafei, Hind
Khalil, Maya
Hassoun, Yasmine
Nasser, Zeina
Tfayli, Arafat
SpringerLink (Online service)
- DOI
-
10.1186/s12885-014-1004-0
- URN
-
urn:nbn:de:1111-201704299484
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mina, Alain
- Rafei, Hind
- Khalil, Maya
- Hassoun, Yasmine
- Nasser, Zeina
- Tfayli, Arafat
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anthracycline Chemotherapy and Cardiotoxicity
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
Value of Echocardiography and Cardiac Magnetic resonance in assessing left ventricular function in breast and gastric cancer patients after Anthracycline Chemotherapy
Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy
Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review
PITX2 DNA methylation predicts response to anthracycline-based chemotherapy in triple negative breast cancer
Anthracycline Chemotherapy and Cardiotoxicity
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
Value of Echocardiography and Cardiac Magnetic resonance in assessing left ventricular function in breast and gastric cancer patients after Anthracycline Chemotherapy
Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy
Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review
PITX2 DNA methylation predicts response to anthracycline-based chemotherapy in triple negative breast cancer
Anthracycline Chemotherapy and Cardiotoxicity
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer
Value of Echocardiography and Cardiac Magnetic resonance in assessing left ventricular function in breast and gastric cancer patients after Anthracycline Chemotherapy
Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy
Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis
Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review